Publication Information

{'id': 'https://openalex.org/W1876354503', 'doi': 'https://doi.org/10.18632/oncotarget.4723', 'title': '<i>BRAF</i> mutation testing with a rapid, fully integrated molecular diagnostics system', 'display_name': '<i>BRAF</i> mutation testing with a rapid, fully integrated molecular diagnostics system', 'publication_year': 2015, 'publication_date': '2015-07-27', 'ids': {'openalex': 'https://openalex.org/W1876354503', 'doi': 'https://doi.org/10.18632/oncotarget.4723', 'mag': '1876354503', 'pmid': 'https://pubmed.ncbi.nlm.nih.gov/26330075', 'pmcid': 'https://www.ncbi.nlm.nih.gov/pmc/articles/4694960'}, 'language': 'en', 'primary_location': {'is_oa': True, 'landing_page_url': 'https://doi.org/10.18632/oncotarget.4723', 'pdf_url': 'https://www.oncotarget.com/article/4723/pdf/', 'source': {'id': 'https://openalex.org/S126644158', 'display_name': 'Oncotarget', 'issn_l': '1949-2553', 'issn': ['1949-2553'], 'is_oa': True, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310316297', 'host_organization_name': 'Impact Journals LLC', 'host_organization_lineage': ['https://openalex.org/P4310316297'], 'host_organization_lineage_names': ['Impact Journals LLC'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': 'publishedVersion', 'is_accepted': True, 'is_published': True}, 'type': 'article', 'type_crossref': 'journal-article', 'indexed_in': ['crossref', 'pubmed'], 'open_access': {'is_oa': True, 'oa_status': 'gold', 'oa_url': 'https://www.oncotarget.com/article/4723/pdf/', 'any_repository_has_fulltext': True}, 'authorships': [{'author_position': 'first', 'author': {'id': 'https://openalex.org/A5071800834', 'display_name': 'Filip Janků', 'orcid': 'https://orcid.org/0000-0002-8123-4065'}, 'institutions': [{'id': 'https://openalex.org/I1343551460', 'display_name': 'The University of Texas MD Anderson Cancer Center', 'ror': 'https://ror.org/04twxam07', 'country_code': 'US', 'type': 'healthcare', 'lineage': ['https://openalex.org/I1343551460']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Filip Janku', 'raw_affiliation_strings': ['Department of Investigational Cancer Therapeutics (Phase I Clinical Trials Program), The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA.'], 'affiliations': [{'raw_affiliation_string': 'Department of Investigational Cancer Therapeutics (Phase I Clinical Trials Program), The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA.', 'institution_ids': ['https://openalex.org/I1343551460']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5060840812', 'display_name': 'Bart Claes', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I4210113372', 'display_name': 'Biocartis (Belgium)', 'ror': 'https://ror.org/030aq8r67', 'country_code': 'BE', 'type': 'company', 'lineage': ['https://openalex.org/I4210113372']}], 'countries': ['BE'], 'is_corresponding': False, 'raw_author_name': 'Bart Claes', 'raw_affiliation_strings': ['Biocartis NV, 2800 Mechelen, Belgium.'], 'affiliations': [{'raw_affiliation_string': 'Biocartis NV, 2800 Mechelen, Belgium.', 'institution_ids': ['https://openalex.org/I4210113372']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5069655635', 'display_name': 'Helen J. Huang', 'orcid': 'https://orcid.org/0000-0002-6308-346X'}, 'institutions': [{'id': 'https://openalex.org/I1343551460', 'display_name': 'The University of Texas MD Anderson Cancer Center', 'ror': 'https://ror.org/04twxam07', 'country_code': 'US', 'type': 'healthcare', 'lineage': ['https://openalex.org/I1343551460']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Helen J. Huang', 'raw_affiliation_strings': ['Department of Investigational Cancer Therapeutics (Phase I Clinical Trials Program), The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA.'], 'affiliations': [{'raw_affiliation_string': 'Department of Investigational Cancer Therapeutics (Phase I Clinical Trials Program), The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA.', 'institution_ids': ['https://openalex.org/I1343551460']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5069777765', 'display_name': 'Gerald S. Falchook', 'orcid': 'https://orcid.org/0000-0001-9165-2191'}, 'institutions': [{'id': 'https://openalex.org/I1343551460', 'display_name': 'The University of Texas MD Anderson Cancer Center', 'ror': 'https://ror.org/04twxam07', 'country_code': 'US', 'type': 'healthcare', 'lineage': ['https://openalex.org/I1343551460']}, {'id': 'https://openalex.org/I172427033', 'display_name': 'Sarah Cannon Research Institute', 'ror': 'https://ror.org/03cp5cj42', 'country_code': 'GB', 'type': 'education', 'lineage': ['https://openalex.org/I172427033']}], 'countries': ['GB', 'US'], 'is_corresponding': False, 'raw_author_name': 'Gerald S. Falchook', 'raw_affiliation_strings': ['Department of Investigational Cancer Therapeutics (Phase I Clinical Trials Program), The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.', 'Sarah Cannon Research Institute at HealthONE, Denver, CO 80218, USA.'], 'affiliations': [{'raw_affiliation_string': 'Department of Investigational Cancer Therapeutics (Phase I Clinical Trials Program), The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.', 'institution_ids': ['https://openalex.org/I1343551460']}, {'raw_affiliation_string': 'Sarah Cannon Research Institute at HealthONE, Denver, CO 80218, USA.', 'institution_ids': ['https://openalex.org/I172427033']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5005663604', 'display_name': 'Benoit Devogelaere', 'orcid': 'https://orcid.org/0000-0003-0881-0502'}, 'institutions': [{'id': 'https://openalex.org/I4210113372', 'display_name': 'Biocartis (Belgium)', 'ror': 'https://ror.org/030aq8r67', 'country_code': 'BE', 'type': 'company', 'lineage': ['https://openalex.org/I4210113372']}], 'countries': ['BE'], 'is_corresponding': False, 'raw_author_name': 'Benoit Devogelaere', 'raw_affiliation_strings': ['Biocartis NV, 2800 Mechelen, Belgium', 'Cartagenia, 3001 Leuven, Belgium'], 'affiliations': [{'raw_affiliation_string': 'Biocartis NV, 2800 Mechelen, Belgium', 'institution_ids': ['https://openalex.org/I4210113372']}, {'raw_affiliation_string': 'Cartagenia, 3001 Leuven, Belgium', 'institution_ids': []}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5050123381', 'display_name': 'Mark Kockx', 'orcid': 'https://orcid.org/0000-0001-9147-2975'}, 'institutions': [{'id': 'https://openalex.org/I4210121202', 'display_name': 'HistoGeneX (Belgium)', 'ror': 'https://ror.org/035xa5s96', 'country_code': 'BE', 'type': 'company', 'lineage': ['https://openalex.org/I4210121202']}], 'countries': ['BE'], 'is_corresponding': False, 'raw_author_name': 'Mark Kockx', 'raw_affiliation_strings': ['HistoGeneX NV, 2600 Berchem, Belgium.'], 'affiliations': [{'raw_affiliation_string': 'HistoGeneX NV, 2600 Berchem, Belgium.', 'institution_ids': ['https://openalex.org/I4210121202']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5080189218', 'display_name': 'Isabelle Vanden Bempt', 'orcid': 'https://orcid.org/0000-0002-3433-555X'}, 'institutions': [{'id': 'https://openalex.org/I4210121202', 'display_name': 'HistoGeneX (Belgium)', 'ror': 'https://ror.org/035xa5s96', 'country_code': 'BE', 'type': 'company', 'lineage': ['https://openalex.org/I4210121202']}], 'countries': ['BE'], 'is_corresponding': False, 'raw_author_name': 'Isabelle Vanden Bempt', 'raw_affiliation_strings': ['HistoGeneX NV, 2600 Berchem, Belgium.'], 'affiliations': [{'raw_affiliation_string': 'HistoGeneX NV, 2600 Berchem, Belgium.', 'institution_ids': ['https://openalex.org/I4210121202']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5023242616', 'display_name': 'Martin Reijans', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I4210113372', 'display_name': 'Biocartis (Belgium)', 'ror': 'https://ror.org/030aq8r67', 'country_code': 'BE', 'type': 'company', 'lineage': ['https://openalex.org/I4210113372']}], 'countries': ['BE'], 'is_corresponding': False, 'raw_author_name': 'Martin Reijans', 'raw_affiliation_strings': ['Biocartis NV, 2800 Mechelen, Belgium.'], 'affiliations': [{'raw_affiliation_string': 'Biocartis NV, 2800 Mechelen, Belgium.', 'institution_ids': ['https://openalex.org/I4210113372']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5005436649', 'display_name': 'Aung Naing', 'orcid': 'https://orcid.org/0000-0002-4803-8513'}, 'institutions': [{'id': 'https://openalex.org/I1343551460', 'display_name': 'The University of Texas MD Anderson Cancer Center', 'ror': 'https://ror.org/04twxam07', 'country_code': 'US', 'type': 'healthcare', 'lineage': ['https://openalex.org/I1343551460']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Aung Naing', 'raw_affiliation_strings': ['Department of Investigational Cancer Therapeutics (Phase I Clinical Trials Program), The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA.'], 'affiliations': [{'raw_affiliation_string': 'Department of Investigational Cancer Therapeutics (Phase I Clinical Trials Program), The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA.', 'institution_ids': ['https://openalex.org/I1343551460']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5045197829', 'display_name': 'Siqing Fu', 'orcid': 'https://orcid.org/0000-0002-1933-0419'}, 'institutions': [{'id': 'https://openalex.org/I1343551460', 'display_name': 'The University of Texas MD Anderson Cancer Center', 'ror': 'https://ror.org/04twxam07', 'country_code': 'US', 'type': 'healthcare', 'lineage': ['https://openalex.org/I1343551460']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Siqing Fu', 'raw_affiliation_strings': ['Department of Investigational Cancer Therapeutics (Phase I Clinical Trials Program), The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA.'], 'affiliations': [{'raw_affiliation_string': 'Department of Investigational Cancer Therapeutics (Phase I Clinical Trials Program), The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA.', 'institution_ids': ['https://openalex.org/I1343551460']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5026538331', 'display_name': 'Sarina A. Piha‐Paul', 'orcid': 'https://orcid.org/0000-0001-9455-1660'}, 'institutions': [{'id': 'https://openalex.org/I1343551460', 'display_name': 'The University of Texas MD Anderson Cancer Center', 'ror': 'https://ror.org/04twxam07', 'country_code': 'US', 'type': 'healthcare', 'lineage': ['https://openalex.org/I1343551460']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Sarina A. Piha-Paul', 'raw_affiliation_strings': ['Department of Investigational Cancer Therapeutics (Phase I Clinical Trials Program), The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA.'], 'affiliations': [{'raw_affiliation_string': 'Department of Investigational Cancer Therapeutics (Phase I Clinical Trials Program), The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA.', 'institution_ids': ['https://openalex.org/I1343551460']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5026095888', 'display_name': 'David S. Hong', 'orcid': 'https://orcid.org/0000-0001-8721-1609'}, 'institutions': [{'id': 'https://openalex.org/I1343551460', 'display_name': 'The University of Texas MD Anderson Cancer Center', 'ror': 'https://ror.org/04twxam07', 'country_code': 'US', 'type': 'healthcare', 'lineage': ['https://openalex.org/I1343551460']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'David S. Hong', 'raw_affiliation_strings': ['Department of Investigational Cancer Therapeutics (Phase I Clinical Trials Program), The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA.'], 'affiliations': [{'raw_affiliation_string': 'Department of Investigational Cancer Therapeutics (Phase I Clinical Trials Program), The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA.', 'institution_ids': ['https://openalex.org/I1343551460']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5085026927', 'display_name': 'Veronica R. Holley', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I1343551460', 'display_name': 'The University of Texas MD Anderson Cancer Center', 'ror': 'https://ror.org/04twxam07', 'country_code': 'US', 'type': 'healthcare', 'lineage': ['https://openalex.org/I1343551460']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Veronica R. Holley', 'raw_affiliation_strings': ['Department of Investigational Cancer Therapeutics (Phase I Clinical Trials Program), The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA.'], 'affiliations': [{'raw_affiliation_string': 'Department of Investigational Cancer Therapeutics (Phase I Clinical Trials Program), The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA.', 'institution_ids': ['https://openalex.org/I1343551460']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5044840107', 'display_name': 'Apostolia M. Tsimberidou', 'orcid': 'https://orcid.org/0000-0003-2713-233X'}, 'institutions': [{'id': 'https://openalex.org/I1343551460', 'display_name': 'The University of Texas MD Anderson Cancer Center', 'ror': 'https://ror.org/04twxam07', 'country_code': 'US', 'type': 'healthcare', 'lineage': ['https://openalex.org/I1343551460']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Apostolia M. Tsimberidou', 'raw_affiliation_strings': ['Department of Investigational Cancer Therapeutics (Phase I Clinical Trials Program), The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA.'], 'affiliations': [{'raw_affiliation_string': 'Department of Investigational Cancer Therapeutics (Phase I Clinical Trials Program), The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA.', 'institution_ids': ['https://openalex.org/I1343551460']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5009720074', 'display_name': 'Vanda M. Stepanek', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I1343551460', 'display_name': 'The University of Texas MD Anderson Cancer Center', 'ror': 'https://ror.org/04twxam07', 'country_code': 'US', 'type': 'healthcare', 'lineage': ['https://openalex.org/I1343551460']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Vanda M. Stepanek', 'raw_affiliation_strings': ['Department of Investigational Cancer Therapeutics (Phase I Clinical Trials Program), The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA.'], 'affiliations': [{'raw_affiliation_string': 'Department of Investigational Cancer Therapeutics (Phase I Clinical Trials Program), The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA.', 'institution_ids': ['https://openalex.org/I1343551460']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5035218748', 'display_name': 'Sapna P. Patel', 'orcid': 'https://orcid.org/0000-0003-1339-1517'}, 'institutions': [{'id': 'https://openalex.org/I1343551460', 'display_name': 'The University of Texas MD Anderson Cancer Center', 'ror': 'https://ror.org/04twxam07', 'country_code': 'US', 'type': 'healthcare', 'lineage': ['https://openalex.org/I1343551460']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Sapna P. Patel', 'raw_affiliation_strings': ['Department of Melanoma Medical Oncology, The University of Texas, MD Anderson Cancer Center, Houston, TX 77030, USA'], 'affiliations': [{'raw_affiliation_string': 'Department of Melanoma Medical Oncology, The University of Texas, MD Anderson Cancer Center, Houston, TX 77030, USA', 'institution_ids': ['https://openalex.org/I1343551460']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5006348751', 'display_name': 'Scott Kopetz', 'orcid': 'https://orcid.org/0000-0001-9647-3416'}, 'institutions': [{'id': 'https://openalex.org/I1343551460', 'display_name': 'The University of Texas MD Anderson Cancer Center', 'ror': 'https://ror.org/04twxam07', 'country_code': 'US', 'type': 'healthcare', 'lineage': ['https://openalex.org/I1343551460']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'E. Scott Kopetz', 'raw_affiliation_strings': ['Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA.'], 'affiliations': [{'raw_affiliation_string': 'Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA.', 'institution_ids': ['https://openalex.org/I1343551460']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5043675371', 'display_name': 'Vivek Subbiah', 'orcid': 'https://orcid.org/0000-0002-6064-6837'}, 'institutions': [{'id': 'https://openalex.org/I1343551460', 'display_name': 'The University of Texas MD Anderson Cancer Center', 'ror': 'https://ror.org/04twxam07', 'country_code': 'US', 'type': 'healthcare', 'lineage': ['https://openalex.org/I1343551460']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Vivek Subbiah', 'raw_affiliation_strings': ['Department of Investigational Cancer Therapeutics (Phase I Clinical Trials Program), The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA.'], 'affiliations': [{'raw_affiliation_string': 'Department of Investigational Cancer Therapeutics (Phase I Clinical Trials Program), The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA.', 'institution_ids': ['https://openalex.org/I1343551460']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5036211173', 'display_name': 'Jennifer J. Wheler', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I1343551460', 'display_name': 'The University of Texas MD Anderson Cancer Center', 'ror': 'https://ror.org/04twxam07', 'country_code': 'US', 'type': 'healthcare', 'lineage': ['https://openalex.org/I1343551460']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Jennifer J. Wheler', 'raw_affiliation_strings': ['Department of Investigational Cancer Therapeutics (Phase I Clinical Trials Program), The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA.'], 'affiliations': [{'raw_affiliation_string': 'Department of Investigational Cancer Therapeutics (Phase I Clinical Trials Program), The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA.', 'institution_ids': ['https://openalex.org/I1343551460']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5105167216', 'display_name': 'Ralph Zinner', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I1343551460', 'display_name': 'The University of Texas MD Anderson Cancer Center', 'ror': 'https://ror.org/04twxam07', 'country_code': 'US', 'type': 'healthcare', 'lineage': ['https://openalex.org/I1343551460']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Ralph G. Zinner', 'raw_affiliation_strings': ['Department of Investigational Cancer Therapeutics (Phase I Clinical Trials Program), The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA.'], 'affiliations': [{'raw_affiliation_string': 'Department of Investigational Cancer Therapeutics (Phase I Clinical Trials Program), The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA.', 'institution_ids': ['https://openalex.org/I1343551460']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5008786567', 'display_name': 'Daniel D. Karp', 'orcid': 'https://orcid.org/0000-0002-5017-328X'}, 'institutions': [{'id': 'https://openalex.org/I1343551460', 'display_name': 'The University of Texas MD Anderson Cancer Center', 'ror': 'https://ror.org/04twxam07', 'country_code': 'US', 'type': 'healthcare', 'lineage': ['https://openalex.org/I1343551460']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Daniel D. Karp', 'raw_affiliation_strings': ['Department of Investigational Cancer Therapeutics (Phase I Clinical Trials Program), The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA.'], 'affiliations': [{'raw_affiliation_string': 'Department of Investigational Cancer Therapeutics (Phase I Clinical Trials Program), The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA.', 'institution_ids': ['https://openalex.org/I1343551460']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5073079562', 'display_name': 'Rajyalakshmi Luthra', 'orcid': 'https://orcid.org/0000-0002-7133-0221'}, 'institutions': [{'id': 'https://openalex.org/I1343551460', 'display_name': 'The University of Texas MD Anderson Cancer Center', 'ror': 'https://ror.org/04twxam07', 'country_code': 'US', 'type': 'healthcare', 'lineage': ['https://openalex.org/I1343551460']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Rajyalakshmi Luthra', 'raw_affiliation_strings': ['Molecular Diagnostics Laboratory, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.'], 'affiliations': [{'raw_affiliation_string': 'Molecular Diagnostics Laboratory, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.', 'institution_ids': ['https://openalex.org/I1343551460']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5023657068', 'display_name': 'Sinchita Roy‐Chowdhuri', 'orcid': 'https://orcid.org/0000-0002-9447-7701'}, 'institutions': [{'id': 'https://openalex.org/I1343551460', 'display_name': 'The University of Texas MD Anderson Cancer Center', 'ror': 'https://ror.org/04twxam07', 'country_code': 'US', 'type': 'healthcare', 'lineage': ['https://openalex.org/I1343551460']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Sinchita Roy-Chowdhuri', 'raw_affiliation_strings': ['Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA'], 'affiliations': [{'raw_affiliation_string': 'Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA', 'institution_ids': ['https://openalex.org/I1343551460']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5111669202', 'display_name': 'Erwin Sablon', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I4210113372', 'display_name': 'Biocartis (Belgium)', 'ror': 'https://ror.org/030aq8r67', 'country_code': 'BE', 'type': 'company', 'lineage': ['https://openalex.org/I4210113372']}], 'countries': ['BE'], 'is_corresponding': False, 'raw_author_name': 'Erwin Sablon', 'raw_affiliation_strings': ['Biocartis NV, 2800 Mechelen, Belgium.'], 'affiliations': [{'raw_affiliation_string': 'Biocartis NV, 2800 Mechelen, Belgium.', 'institution_ids': ['https://openalex.org/I4210113372']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5076426660', 'display_name': 'Funda Meric‐Bernstam', 'orcid': 'https://orcid.org/0000-0001-6816-6072'}, 'institutions': [{'id': 'https://openalex.org/I1343551460', 'display_name': 'The University of Texas MD Anderson Cancer Center', 'ror': 'https://ror.org/04twxam07', 'country_code': 'US', 'type': 'healthcare', 'lineage': ['https://openalex.org/I1343551460']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Funda Meric-Bernstam', 'raw_affiliation_strings': ['Department of Investigational Cancer Therapeutics (Phase I Clinical Trials Program), The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA.'], 'affiliations': [{'raw_affiliation_string': 'Department of Investigational Cancer Therapeutics (Phase I Clinical Trials Program), The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA.', 'institution_ids': ['https://openalex.org/I1343551460']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5063366190', 'display_name': 'Geert Maertens', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I4210113372', 'display_name': 'Biocartis (Belgium)', 'ror': 'https://ror.org/030aq8r67', 'country_code': 'BE', 'type': 'company', 'lineage': ['https://openalex.org/I4210113372']}], 'countries': ['BE'], 'is_corresponding': False, 'raw_author_name': 'Geert Maertens', 'raw_affiliation_strings': ['Biocartis NV, 2800 Mechelen, Belgium.'], 'affiliations': [{'raw_affiliation_string': 'Biocartis NV, 2800 Mechelen, Belgium.', 'institution_ids': ['https://openalex.org/I4210113372']}]}, {'author_position': 'last', 'author': {'id': 'https://openalex.org/A5053481267', 'display_name': 'Razelle Kurzrock', 'orcid': 'https://orcid.org/0000-0003-4110-1214'}, 'institutions': [{'id': 'https://openalex.org/I36258959', 'display_name': 'University of California, San Diego', 'ror': 'https://ror.org/0168r3w48', 'country_code': 'US', 'type': 'education', 'lineage': ['https://openalex.org/I36258959']}, {'id': 'https://openalex.org/I1343551460', 'display_name': 'The University of Texas MD Anderson Cancer Center', 'ror': 'https://ror.org/04twxam07', 'country_code': 'US', 'type': 'healthcare', 'lineage': ['https://openalex.org/I1343551460']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Razelle Kurzrock', 'raw_affiliation_strings': ['Center for Personalized Cancer Therapy, Moores Cancer Center, The University of California San Diego, La Jolla, CA 92093, USA.', 'Department of Investigational Cancer Therapeutics (Phase I Clinical Trials Program), The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.'], 'affiliations': [{'raw_affiliation_string': 'Center for Personalized Cancer Therapy, Moores Cancer Center, The University of California San Diego, La Jolla, CA 92093, USA.', 'institution_ids': ['https://openalex.org/I36258959']}, {'raw_affiliation_string': 'Department of Investigational Cancer Therapeutics (Phase I Clinical Trials Program), The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.', 'institution_ids': ['https://openalex.org/I1343551460']}]}], 'institution_assertions': [], 'countries_distinct_count': 3, 'institutions_distinct_count': 5, 'corresponding_author_ids': [], 'corresponding_institution_ids': [], 'apc_list': None, 'apc_paid': None, 'fwci': 3.413, 'has_fulltext': True, 'fulltext_origin': 'pdf', 'cited_by_count': 47, 'citation_normalized_percentile': {'value': 0.856575, 'is_in_top_1_percent': False, 'is_in_top_10_percent': False}, 'cited_by_percentile_year': {'min': 95, 'max': 96}, 'biblio': {'volume': '6', 'issue': '29', 'first_page': '26886', 'last_page': '26894'}, 'is_retracted': False, 'is_paratext': False, 'primary_topic': {'id': 'https://openalex.org/T11533', 'display_name': 'Melanoma and MAPK Pathways', 'score': 0.9999, 'subfield': {'id': 'https://openalex.org/subfields/1312', 'display_name': 'Molecular Biology'}, 'field': {'id': 'https://openalex.org/fields/13', 'display_name': 'Biochemistry, Genetics and Molecular Biology'}, 'domain': {'id': 'https://openalex.org/domains/1', 'display_name': 'Life Sciences'}}, 'topics': [{'id': 'https://openalex.org/T11533', 'display_name': 'Melanoma and MAPK Pathways', 'score': 0.9999, 'subfield': {'id': 'https://openalex.org/subfields/1312', 'display_name': 'Molecular Biology'}, 'field': {'id': 'https://openalex.org/fields/13', 'display_name': 'Biochemistry, Genetics and Molecular Biology'}, 'domain': {'id': 'https://openalex.org/domains/1', 'display_name': 'Life Sciences'}}, {'id': 'https://openalex.org/T10755', 'display_name': 'HER2/EGFR in Cancer Research', 'score': 0.9953, 'subfield': {'id': 'https://openalex.org/subfields/2730', 'display_name': 'Oncology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T11067', 'display_name': 'Colorectal Cancer Treatments and Studies', 'score': 0.993, 'subfield': {'id': 'https://openalex.org/subfields/2730', 'display_name': 'Oncology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}], 'keywords': [{'id': 'https://openalex.org/keywords/concordance', 'display_name': 'Concordance', 'score': 0.81579137}, {'id': 'https://openalex.org/keywords/turnaround-time', 'display_name': 'Turnaround time', 'score': 0.6098369}, {'id': 'https://openalex.org/keywords/molecular-diagnostics', 'display_name': 'Molecular diagnostics', 'score': 0.4614905}], 'concepts': [{'id': 'https://openalex.org/C160798450', 'wikidata': 'https://www.wikidata.org/wiki/Q4230870', 'display_name': 'Concordance', 'level': 2, 'score': 0.81579137}, {'id': 'https://openalex.org/C71924100', 'wikidata': 'https://www.wikidata.org/wiki/Q11190', 'display_name': 'Medicine', 'level': 0, 'score': 0.74225336}, {'id': 'https://openalex.org/C176553487', 'wikidata': 'https://www.wikidata.org/wiki/Q7855819', 'display_name': 'Turnaround time', 'level': 2, 'score': 0.6098369}, {'id': 'https://openalex.org/C501734568', 'wikidata': 'https://www.wikidata.org/wiki/Q42918', 'display_name': 'Mutation', 'level': 3, 'score': 0.56783503}, {'id': 'https://openalex.org/C143998085', 'wikidata': 'https://www.wikidata.org/wiki/Q162555', 'display_name': 'Oncology', 'level': 1, 'score': 0.5051263}, {'id': 'https://openalex.org/C179786068', 'wikidata': 'https://www.wikidata.org/wiki/Q16257937', 'display_name': 'Molecular diagnostics', 'level': 2, 'score': 0.4614905}, {'id': 'https://openalex.org/C51679486', 'wikidata': 'https://www.wikidata.org/wiki/Q380546', 'display_name': 'DNA sequencing', 'level': 3, 'score': 0.44543177}, {'id': 'https://openalex.org/C126322002', 'wikidata': 'https://www.wikidata.org/wiki/Q11180', 'display_name': 'Internal medicine', 'level': 1, 'score': 0.44167584}, {'id': 'https://openalex.org/C60644358', 'wikidata': 'https://www.wikidata.org/wiki/Q128570', 'display_name': 'Bioinformatics', 'level': 1, 'score': 0.23930734}, {'id': 'https://openalex.org/C54355233', 'wikidata': 'https://www.wikidata.org/wiki/Q7162', 'display_name': 'Genetics', 'level': 1, 'score': 0.21868747}, {'id': 'https://openalex.org/C104317684', 'wikidata': 'https://www.wikidata.org/wiki/Q7187', 'display_name': 'Gene', 'level': 2, 'score': 0.18408468}, {'id': 'https://openalex.org/C86803240', 'wikidata': 'https://www.wikidata.org/wiki/Q420', 'display_name': 'Biology', 'level': 0, 'score': 0.15210122}, {'id': 'https://openalex.org/C41008148', 'wikidata': 'https://www.wikidata.org/wiki/Q21198', 'display_name': 'Computer science', 'level': 0, 'score': 0.0}, {'id': 'https://openalex.org/C111919701', 'wikidata': 'https://www.wikidata.org/wiki/Q9135', 'display_name': 'Operating system', 'level': 1, 'score': 0.0}], 'mesh': [{'descriptor_ui': 'D004252', 'descriptor_name': 'DNA Mutational Analysis', 'qualifier_ui': 'Q000379', 'qualifier_name': 'methods', 'is_major_topic': True}, {'descriptor_ui': 'D008545', 'descriptor_name': 'Melanoma', 'qualifier_ui': 'Q000175', 'qualifier_name': 'diagnosis', 'is_major_topic': True}, {'descriptor_ui': 'D009369', 'descriptor_name': 'Neoplasms', 'qualifier_ui': 'Q000175', 'qualifier_name': 'diagnosis', 'is_major_topic': True}, {'descriptor_ui': 'D048493', 'descriptor_name': 'Proto-Oncogene Proteins B-raf', 'qualifier_ui': 'Q000235', 'qualifier_name': 'genetics', 'is_major_topic': True}, {'descriptor_ui': 'D012878', 'descriptor_name': 'Skin Neoplasms', 'qualifier_ui': 'Q000175', 'qualifier_name': 'diagnosis', 'is_major_topic': True}, {'descriptor_ui': 'D004252', 'descriptor_name': 'DNA Mutational Analysis', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D005557', 'descriptor_name': 'Formaldehyde', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D005557', 'descriptor_name': 'Formaldehyde', 'qualifier_ui': 'Q000737', 'qualifier_name': 'chemistry', 'is_major_topic': False}, {'descriptor_ui': 'D059014', 'descriptor_name': 'High-Throughput Nucleotide Sequencing', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D006801', 'descriptor_name': 'Humans', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D008545', 'descriptor_name': 'Melanoma', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D008545', 'descriptor_name': 'Melanoma', 'qualifier_ui': 'Q000235', 'qualifier_name': 'genetics', 'is_major_topic': False}, {'descriptor_ui': 'D008545', 'descriptor_name': 'Melanoma', 'qualifier_ui': 'Q000378', 'qualifier_name': 'metabolism', 'is_major_topic': False}, {'descriptor_ui': 'D009154', 'descriptor_name': 'Mutation', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D009369', 'descriptor_name': 'Neoplasms', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D009369', 'descriptor_name': 'Neoplasms', 'qualifier_ui': 'Q000235', 'qualifier_name': 'genetics', 'is_major_topic': False}, {'descriptor_ui': 'D009369', 'descriptor_name': 'Neoplasms', 'qualifier_ui': 'Q000378', 'qualifier_name': 'metabolism', 'is_major_topic': False}, {'descriptor_ui': 'D016612', 'descriptor_name': 'Paraffin Embedding', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D057089', 'descriptor_name': 'Pathology, Molecular', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D048493', 'descriptor_name': 'Proto-Oncogene Proteins B-raf', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D060888', 'descriptor_name': 'Real-Time Polymerase Chain Reaction', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D015203', 'descriptor_name': 'Reproducibility of Results', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D012878', 'descriptor_name': 'Skin Neoplasms', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D012878', 'descriptor_name': 'Skin Neoplasms', 'qualifier_ui': 'Q000235', 'qualifier_name': 'genetics', 'is_major_topic': False}, {'descriptor_ui': 'D012878', 'descriptor_name': 'Skin Neoplasms', 'qualifier_ui': 'Q000378', 'qualifier_name': 'metabolism', 'is_major_topic': False}], 'locations_count': 4, 'locations': [{'is_oa': True, 'landing_page_url': 'https://doi.org/10.18632/oncotarget.4723', 'pdf_url': 'https://www.oncotarget.com/article/4723/pdf/', 'source': {'id': 'https://openalex.org/S126644158', 'display_name': 'Oncotarget', 'issn_l': '1949-2553', 'issn': ['1949-2553'], 'is_oa': True, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310316297', 'host_organization_name': 'Impact Journals LLC', 'host_organization_lineage': ['https://openalex.org/P4310316297'], 'host_organization_lineage_names': ['Impact Journals LLC'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': 'publishedVersion', 'is_accepted': True, 'is_published': True}, {'is_oa': True, 'landing_page_url': 'https://europepmc.org/articles/pmc4694960', 'pdf_url': 'https://europepmc.org/articles/pmc4694960?pdf=render', 'source': {'id': 'https://openalex.org/S4306400806', 'display_name': 'Europe PMC (PubMed Central)', 'issn_l': None, 'issn': None, 'is_oa': True, 'is_in_doaj': False, 'is_core': False, 'host_organization': 'https://openalex.org/I1303153112', 'host_organization_name': 'European Bioinformatics Institute', 'host_organization_lineage': ['https://openalex.org/I1303153112'], 'host_organization_lineage_names': ['European Bioinformatics Institute'], 'type': 'repository'}, 'license': 'cc-by', 'license_id': 'https://openalex.org/licenses/cc-by', 'version': 'publishedVersion', 'is_accepted': True, 'is_published': True}, {'is_oa': True, 'landing_page_url': 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4694960', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S2764455111', 'display_name': 'PubMed Central', 'issn_l': None, 'issn': None, 'is_oa': True, 'is_in_doaj': False, 'is_core': False, 'host_organization': 'https://openalex.org/I1299303238', 'host_organization_name': 'National Institutes of Health', 'host_organization_lineage': ['https://openalex.org/I1299303238'], 'host_organization_lineage_names': ['National Institutes of Health'], 'type': 'repository'}, 'license': None, 'license_id': None, 'version': 'publishedVersion', 'is_accepted': True, 'is_published': True}, {'is_oa': False, 'landing_page_url': 'https://pubmed.ncbi.nlm.nih.gov/26330075', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S4306525036', 'display_name': 'PubMed', 'issn_l': None, 'issn': None, 'is_oa': False, 'is_in_doaj': False, 'is_core': False, 'host_organization': 'https://openalex.org/I1299303238', 'host_organization_name': 'National Institutes of Health', 'host_organization_lineage': ['https://openalex.org/I1299303238'], 'host_organization_lineage_names': ['National Institutes of Health'], 'type': 'repository'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}], 'best_oa_location': {'is_oa': True, 'landing_page_url': 'https://doi.org/10.18632/oncotarget.4723', 'pdf_url': 'https://www.oncotarget.com/article/4723/pdf/', 'source': {'id': 'https://openalex.org/S126644158', 'display_name': 'Oncotarget', 'issn_l': '1949-2553', 'issn': ['1949-2553'], 'is_oa': True, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310316297', 'host_organization_name': 'Impact Journals LLC', 'host_organization_lineage': ['https://openalex.org/P4310316297'], 'host_organization_lineage_names': ['Impact Journals LLC'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': 'publishedVersion', 'is_accepted': True, 'is_published': True}, 'sustainable_development_goals': [{'display_name': 'Good health and well-being', 'id': 'https://metadata.un.org/sdg/3', 'score': 0.54}], 'grants': [], 'datasets': [], 'versions': [], 'referenced_works_count': 16, 'referenced_works': ['https://openalex.org/W1965271384', 'https://openalex.org/W2011042089', 'https://openalex.org/W2017375813', 'https://openalex.org/W2043696829', 'https://openalex.org/W2051165598', 'https://openalex.org/W2055388753', 'https://openalex.org/W2079421845', 'https://openalex.org/W2086924064', 'https://openalex.org/W2104830962', 'https://openalex.org/W2106494998', 'https://openalex.org/W2106543129', 'https://openalex.org/W2128542677', 'https://openalex.org/W2149372853', 'https://openalex.org/W2151281047', 'https://openalex.org/W2329648702', 'https://openalex.org/W2399530872'], 'related_works': ['https://openalex.org/W648938440', 'https://openalex.org/W4220795960', 'https://openalex.org/W2896967464', 'https://openalex.org/W2891994822', 'https://openalex.org/W2789177613', 'https://openalex.org/W2729455050', 'https://openalex.org/W2108427450', 'https://openalex.org/W2104328188', 'https://openalex.org/W1995306494', 'https://openalex.org/W1601684588'], 'abstract_inverted_index': {'//': [0], 'Filip': [1, 276], 'Janku': [2], '1,': [3, 19, 124], '*': [4, 9, 265], ',': [5, 10, 15, 21, 26, 30, 35, 39, 43, 47, 52, 57, 62, 67, 72, 77, 82, 86, 91, 96, 101, 105, 109, 113, 117, 121], 'Bart': [6], 'Claes': [7], '2,': [8, 24], 'Helen': [11], 'J.': [12, 88], 'Huang': [13], '1': [14, 42, 46, 51, 56, 61, 66, 71, 85, 90, 95, 100, 116, 126], 'Gerald': [16], 'S.': [17, 54], 'Falchook': [18], '3': [20, 155], 'Benoit': [22], 'Devogelaere': [23], '9': [25, 254, 477], 'Mark': [27], 'Kockx': [28], '10': [29, 34, 259], 'Isabelle': [31], 'Vanden': [32], 'Bempt': [33], 'Martin': [36], 'Reijans': [37], '2': [38, 112, 120, 149, 498], 'Aung': [40], 'Naing': [41], 'Siqing': [44], 'Fu': [45], 'Sarina': [48], 'A.': [49], 'Piha-Paul': [50], 'David': [53], 'Hong': [55], 'Veronica': [58], 'R.': [59], 'Holley': [60], 'Apostolia': [63], 'M.': [64, 69], 'Tsimberidou': [65], 'Vanda': [68], 'Stepanek': [70], 'Sapna': [73], 'P.': [74], 'Patel': [75], '4': [76, 166], 'E.': [78], 'Scott': [79], 'Kopetz': [80], '5': [81, 184], 'Vivek': [83], 'Subbiah': [84], 'Jennifer': [87], 'Wheler': [89], 'Ralph': [92], 'G.': [93], 'Zinner': [94], 'Daniel': [97], 'D.': [98], 'Karp': [99], 'Rajyalakshmi': [102], 'Luthra': [103], '6': [104, 202], 'Sinchita': [106], 'Roy-Chowdhuri': [107], '7': [108, 218], 'Erwin': [110], 'Sablon': [111], 'Funda': [114], 'Meric-Bernstam': [115], 'Geert': [118], 'Maertens': [119], 'Razelle': [122], 'Kurzrock': [123], '8': [125, 234], 'Department': [127, 167, 185, 219], 'of': [128, 139, 168, 174, 186, 192, 208, 220, 224, 245, 308, 311, 396, 415, 438, 458, 500, 508, 514], 'Investigational': [129], 'Cancer': [130, 143, 178, 196, 212, 228, 238, 241], 'Therapeutics': [131], '(Phase': [132], 'I': [133], 'Clinical': [134, 376], 'Trials': [135], 'Program),': [136], 'The': [137, 172, 190, 206, 222, 243, 317, 426, 479], 'University': [138, 173, 191, 207, 223, 244], 'Texas': [140, 175, 193, 209, 225], 'MD': [141, 176, 194, 210, 226], 'Anderson': [142, 177, 195, 211, 227], 'Center,': [144, 179, 197, 213, 229, 242], 'Houston,': [145, 180, 198, 214, 230], 'TX': [146, 181, 199, 215, 231], '77030,': [147, 182, 200, 216, 232], 'USA': [148, 165, 183, 201, 217, 233, 253], 'Biocartis': [150], 'NV,': [151, 261], '2800': [152], 'Mechelen,': [153], 'Belgium': [154, 258, 264], 'Sarah': [156], 'Cannon': [157], 'Research': [158], 'Institute': [159], 'at': [160], 'HealthONE,': [161], 'Denver,': [162], 'CO': [163], '80218,': [164], 'Melanoma': [169], 'Medical': [170, 188], 'Oncology,': [171, 189], 'Gastrointestinal': [187], 'Molecular': [203], 'Diagnostics': [204], 'Laboratory,': [205], 'Pathology,': [221], 'Center': [235], 'for': [236, 305, 476], 'Personalized': [237], 'Therapy,': [239], 'Moores': [240], 'California': [246], 'San': [247], 'Diego,': [248], 'La': [249], 'Jolla,': [250], 'CA': [251], '92093,': [252], 'Cartagenia,': [255], '3001': [256], 'Leuven,': [257], 'HistoGeneX': [260], '2600': [262], 'Berchem,': [263], 'These': [266], 'authors': [267], 'have': [268], 'contributed': [269], 'equally': [270], 'to': [271, 332, 338, 473, 489], 'this': [272], 'work': [273], 'Correspondence': [274], 'to:': [275], 'Janku,': [277], 'e-mail:': [278], '[email protected]': [279], 'Keywords:': [280], 'BRAF,': [281], 'rapid,': [282], 'integrated,': [283], 'qPCR': [284], 'Received:': [285], 'June': [286], '03,': [287], '2015': [288, 292, 296], 'Accepted:': [289], 'July': [290, 294], '17,': [291], 'Published:': [293], '27,': [295], 'ABSTRACT': [297], 'Fast': [298], 'and': [299, 314, 327, 350, 370, 409, 428, 451, 468, 504, 528], 'accurate': [300], 'diagnostic': [301], 'systems': [302], 'are': [303], 'needed': [304], 'further': [306], 'implementation': [307], 'precision': [309], 'therapy': [310], 'BRAF-': [312], 'mutant': [313], 'other': [315, 333, 533], 'cancers.': [316], 'novel': [318], 'Idylla': [319, 337, 408, 417, 427, 450, 480, 524], 'TM': [320, 481], 'BRAF': [321, 340, 361, 403, 419, 445, 482, 539], 'Mutation': [322, 363, 483], 'Test': [323, 364, 484], 'has': [324, 529], 'high': [325, 530], 'sensitivity': [326], 'shorter': [328], 'turnaround': [329], 'times': [330], 'compared': [331, 351], 'methods.': [334], 'We': [335], 'used': [336, 475, 535], 'detect': [339], 'V600': [341, 362, 420], 'mutations': [342, 404, 421], 'in': [343, 422], 'archived': [344], 'formalin-fixed': [345], 'paraffin-embedded': [346], '(FFPE)': [347], 'tumor': [348, 399, 441], 'samples': [349, 400, 442], 'these': [352], 'results': [353, 411, 430, 454, 486, 490], 'with': [354, 371, 402, 444, 496, 532], 'those': [355, 372], 'obtained': [356, 373], 'using': [357], 'the': [358, 407, 449, 462, 505, 509, 512, 523], 'cobas': [359, 410], '4800': [360], 'or': [365, 390], 'MiSeq': [366, 429], 'deep': [367], 'sequencing': [368], 'system': [369], 'by': [374], 'a': [375, 435], 'Laboratory': [377], 'Improvement': [378], 'Amendments': [379], '(CLIA)-certified': [380], 'laboratory': [381, 453], 'employing': [382], 'polymerase': [383], 'chain': [384], 'reaction–based': [385], 'sequencing,': [386], 'mass': [387], 'spectrometric': [388], 'detection,': [389], 'next-generation': [391], 'sequencing.': [392], 'In': [393, 434, 517], 'one': [394], 'set': [395, 437], '60': [397], 'FFPE': [398, 440, 470], '(15': [401], 'per': [405, 447], 'Idylla),': [406, 448], 'had': [412, 431, 472], 'an': [413, 456], 'agreement': [414, 457], '97%.': [416], 'detected': [418], 'two': [423], 'additional': [424], 'samples.': [425], '100%': [432], 'concordance.': [433], 'separate': [436], '100': [439], '(64': [443], 'mutation': [446], 'CLIA-certified': [452], 'demonstrated': [455], '96%': [459], 'even': [460], 'though': [461], 'tests': [463], 'were': [464], 'not': [465], 'performed': [466], 'simultaneously': [467], 'different': [469], 'blocks': [471], 'be': [474], 'cases.': [478], 'produced': [485], 'quickly': [487], '(sample': [488], 'time': [491], 'was': [492], 'about': [493, 497], '90': [494], 'minutes': [495, 499], 'hands': [501], 'on': [502], 'time)': [503], 'closed': [506], 'nature': [507], 'cartridge': [510], 'eliminates': [511], 'risk': [513], 'PCR': [515], 'contamination.': [516], 'conclusion,': [518], 'our': [519], 'observations': [520], 'demonstrate': [521], 'that': [522], 'test': [525], 'is': [526], 'rapid': [527], 'concordance': [531], 'routinely': [534], 'but': [536], 'more': [537], 'complex': [538], 'mutation–detecting': [540], 'tests.': [541]}, 'cited_by_api_url': 'https://api.openalex.org/works?filter=cites:W1876354503', 'counts_by_year': [{'year': 2024, 'cited_by_count': 1}, {'year': 2022, 'cited_by_count': 5}, {'year': 2021, 'cited_by_count': 3}, {'year': 2020, 'cited_by_count': 4}, {'year': 2019, 'cited_by_count': 7}, {'year': 2018, 'cited_by_count': 5}, {'year': 2017, 'cited_by_count': 12}, {'year': 2016, 'cited_by_count': 8}, {'year': 2015, 'cited_by_count': 2}], 'updated_date': '2024-12-14T09:00:34.924118', 'created_date': '2016-06-24'}